Boxer Capital, LLC Reata Pharmaceuticals Inc Transaction History

Boxer Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $15.8 Million - $21.1 Million	200,000 Added 16.26%	1,430,004 $146 Million
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $199,261 - $378,821	-8,996 Reduced 0.73%	1,230,004 $46.7 Million
Q1 2022 May 16, 2022	BUY	$24.12 - $39.6 $29.9 Million - $49.1 Million	1,239,000 New	1,239,000 $40.6 Million
Q1 2019 May 15, 2019	SELL	$51.9 - $101.79 $2.6 Million - $5.09 Million	-50,000 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$48.76 - $76.44 $17.1 Million - $26.8 Million	-350,000 Reduced 87.5%	50,000 $2.81 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $2.67 Million - $6.9 Million	75,000 Added 23.08%	400,000 $32.7 Million
Q1 2018 May 15, 2018	BUY	$20.0 - $30.19 $6.5 Million - $9.81 Million	325,000 New	325,000 $6.67 Million
Q4 2017 Feb 14, 2018	SELL	$22.39 - $33.27 $4.48 Million - $6.65 Million	-200,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $5.26 Million - $6.38 Million	200,000	200,000 $6.22 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.